| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3339567 | Allergologia et Immunopathologia | 2016 | 9 Pages |
Abstract
Physicians awareness of PID has been rising dramatically in Iran, ensuring an increasing number of patients being diagnosed and treated. More effective treatment services, including health insurance coverage and drug availability are needed to improve the outcome of PID patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
M. Nabavi, S. Arshi, M.H. Bemanian, A. Aghamohammadi, D. Mansouri, M. Hedayat, A. Nateghian, S. Noorbakhsh, F. Ehsanipour, M. Faranoush, R. Shakeri, M. Mesdaghi, B. Taghvaei, B. Ghalebaghi, D. Babaie, A. Bahrami, M. Fallahpour, H. Esmaeilzadeh,